Details for Patent: 5,747,472
Summary for Patent: 5,747,472
| Title: | Therapeutic methods for using ARA-G derivatives |
| Abstract: | 6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumour therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed. |
| Inventor(s): | Thomas Anthony Krenitsky, Devron Randolph Averett, George Walter Koszalka, Gerald Wolberg |
| Assignee: | Novartis AG , Novartis Pharma AG |
| Application Number: | US08/456,186 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,747,472
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,747,472
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 9015914 | Jul 19, 1990 |
International Family Members for US Patent 5,747,472
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 151637 | ⤷ Start Trial | |||
| Australia | 641533 | ⤷ Start Trial | |||
| Australia | 8196091 | ⤷ Start Trial | |||
| Canada | 2087543 | ⤷ Start Trial | |||
| Cyprus | 2165 | ⤷ Start Trial | |||
| Germany | 69125715 | ⤷ Start Trial | |||
| Denmark | 0539479 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
